Carregant...

721. In Vitro Activity of Cefiderocol Against Gram-Negative Clinical Isolates From New York City

BACKGROUND: Multidrug-resistant Gram-negative bacteria have become a serious problem in hospitals worldwide. Cefiderocol (CFDC) is a novel siderophore cephalosporin with activity against a wide range of carbapenemase- and ESBL-producing bacteria. We tested the activity of CFDC against (1) a recent c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Iregui, Alejandro, Khan, Zeb, Landman, David, Quale, John M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811323/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.789
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!